Ruf A, Patscheke H
Institute for Medical Laboratory Diagnostics, Klinikum Karlsruhe, Germany.
Br J Haematol. 1995 Aug;90(4):791-6. doi: 10.1111/j.1365-2141.1995.tb05197.x.
Mutual contacts and platelet-expressed fibrinogen seem to be required for the stimulation of neutrophils by activated platelets. The beta 2-integrins CD11b/CD18 and CD11c/CD18 are potential receptors for fibrinogen on neutrophils. In order to investigate whether binding of fibrinogen to these integrins is involved, monoclonal antibodies (MoAbs) and Gly-Pro-Arg-Pro (GPRP) peptide that inhibits fibrinogen binding to CD11c/CD18 were checked for their effects on the interaction of activated platelets and neutrophils. The luminol-amplified chemiluminescence (CL) as a measure for the oxidative burst of neutrophils was recorded simultaneously to the platelet aggregation in mixed cell suspensions. The adhesion of platelets and neutrophils was determined microscopically. The thromboxane A2 mimetic U46619 was used as a potent platelet agonist but that does not stimulate neutrophils. aggregation and a strong CL of neutrophils. The platelet-induced activation of neutrophils required added fibrinogen which fibronectin or thrombospondin could not substitute for. Cytochalasin D (Cyto D) that blocks actin polymerization totally abrogated the platelet-induced Cl of neutrophils. The MoAb OKM1 against CD11b, which blocks fibrinogen binding to CD11b/CD18 as well as the MoAbs IOT16 and IOT18 directed against CD11a and CD18, respectively, had no effect. In contrast, the MoAb LeuM5 which inhibits the binding of fibrinogen to CD11c/CD18 revealed a strong inhibition. Furthermore, GPRP peptide which CD11c/CD18 recognizes on the A alpha-chain of fibrinogen also strongly inhibited the platelet-induced CL of neutrophils, whereas control peptides such as Gly-His-Arg-Pro (GHRP) or Gly-Pro-Gly-Gly (GPGG) had no effect. In contrast to the platelet-induced CL of neutrophils, Cyto D, MoAb against CD11c and GPRP peptide did not inhibit the CL induced by FMLP and PAF in pure neutrophil suspensions. They also did not affect U46619-induced platelet aggregation. The adhesion of platelets and neutrophils was neither dependent on added fibrinogen nor inhibited by Cyto D, MoAb against CD11c and the GPRP-peptide. Therefore fibrinogen and actin polymerization seem not to be required for the adhesion of neutrophils to platelets. However, the activation of neutrophils depends on the interaction of CD11c/CD18 with the A alpha-chain of platelet-expressed fibrinogen and the contractile system of neutrophils.
活化血小板刺激中性粒细胞似乎需要相互接触以及血小板表达的纤维蛋白原。β2整合素CD11b/CD18和CD11c/CD18是中性粒细胞上纤维蛋白原的潜在受体。为了研究纤维蛋白原与这些整合素的结合是否参与其中,检测了单克隆抗体(MoAb)和抑制纤维蛋白原与CD11c/CD18结合的甘氨酰-脯氨酰-精氨酰-脯氨酸(GPRP)肽对活化血小板与中性粒细胞相互作用的影响。在混合细胞悬液中,同时记录鲁米诺增强的化学发光(CL)作为中性粒细胞氧化爆发的指标以及血小板聚集情况。通过显微镜观察血小板与中性粒细胞的黏附。血栓素A2模拟物U46619用作有效的血小板激动剂,但不刺激中性粒细胞。血小板聚集和中性粒细胞强烈的CL反应。血小板诱导的中性粒细胞活化需要添加纤维蛋白原,而纤连蛋白或血小板反应蛋白不能替代。完全阻断肌动蛋白聚合的细胞松弛素D(Cyto D)完全消除了血小板诱导的中性粒细胞CL反应。抗CD11b的单克隆抗体OKM1可阻断纤维蛋白原与CD11b/CD18的结合,以及分别针对CD11a和CD18的单克隆抗体IOT16和IOT18均无作用。相反,抑制纤维蛋白原与CD11c/CD18结合的单克隆抗体LeuM5显示出强烈的抑制作用。此外,CD11c/CD18在纤维蛋白原Aα链上识别的GPRP肽也强烈抑制血小板诱导的中性粒细胞CL反应,而对照肽如甘氨酰-组氨酰-精氨酰-脯氨酸(GHRP)或甘氨酰-脯氨酰-甘氨酰-甘氨酸(GPGG)则无作用。与血小板诱导的中性粒细胞CL反应不同,Cyto D、抗CD11c单克隆抗体和GPRP肽不抑制纯中性粒细胞悬液中由FMLP和PAF诱导的CL反应。它们也不影响U46619诱导的血小板聚集。血小板与中性粒细胞的黏附既不依赖于添加的纤维蛋白原,也不受Cyto D、抗CD11c单克隆抗体和GPRP肽的抑制。因此,纤维蛋白原和肌动蛋白聚合似乎不是中性粒细胞与血小板黏附所必需的。然而,中性粒细胞的活化取决于CD11c/CD18与血小板表达的纤维蛋白原Aα链以及中性粒细胞收缩系统的相互作用。